N-(6-(6-bromo-[1,2,4]triazolo[4,3-a]pyridin-3-ylthio)imidazo[1,2-b]pyridazin-2-yl)cyclopropanecarboxamide → 3-(2-(Cyclopropanecarboxamido)imidazo[1,2-b]pyridazin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid
반응식
[SH:1][C:2]1[N:6]2[CH:7]=[C:8]([C:11]([OH:13])=[O:12])[CH:9]=[CH:10][C:5]2=[N:4][N:3]=1.BrC1C=CC2N(C(S[C:25]3[CH:26]=[CH:27][C:28]4[N:29]([CH:31]=[C:32]([NH:34][C:35]([CH:37]5[CH2:39][CH2:38]5)=[O:36])[N:33]=4)[N:30]=3)=NN=2)C=1>>[CH:37]1([C:35]([NH:34][C:32]2[N:33]=[C:28]3[CH:27]=[CH:26][C:25]([S:1][C:2]4[N:6]5[CH:7]=[C:8]([C:11]([OH:13])=[O:12])[CH:9]=[CH:10][C:5]5=[N:4][N:3]=4)=[N:30][N:29]3[CH:31]=2)=[O:36])[CH2:38][CH2:39]1참가 물질
3
실험 절차
Compound 33 was prepared from 3-mercapto-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid following the procedure described in the synthesis of compound 4. 1H NMR (400 MHz, CDCl3—CD3OD 10:1) δ ppm 9.03 (bs, 1 H), 8.01 (d, J=9.1 Hz, 1 H), 7.87 (d, J=9.6 Hz, 1 H), 7.68 (d, J=9.4 Hz, 1 H), 7.36 (m, 1H), 7.09 (d, J=9.3 Hz, 1 H), 2.84 (m, 1 H), 1.72 (m, 1 H), 0.97 (m, 2 H), 0.84 (m, 2H) ESI-MS:m/z 396.1 (M+H)+.